CDKN2 mutations in melanoma

Cancer Surveys

Volumn 26, Issue , 1996, Pages 115-132

  Dracopoli, Nicholas C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CHROMOSOME 9P; CYTOGENETICS; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MELANOMA; PRIORITY JOURNAL; REVIEW;

CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; GENES, TUMOR SUPPRESSOR; GENETIC HETEROGENEITY; HETEROZYGOTE; HUMANS; MELANOMA; MUTATION; PERIODICITY; SKIN NEOPLASMS;

EID: 0029548430     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Bale SJ, Dracopoli NC, Tucker MA et al (1989) Mapping of the gene for hereditary cutaneous malignant melanoma. New England Journal of Medicine 320 1367-1372
2. Brash DE, Rudolph JA, Simon JA et al (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proceedings of the National Academy of Sciences of the USA 88 10124-10128
3. Cairns P, Mao L, Merlo A et al (1994) Rates of p16 (MTS1) mutations in primary rumors with 9p loss. Science 265 415-417
4. Caldas C, Hahn SA, da Costa LT et al (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genetics 8 27-32
5. Cannon-Albright LA, Goldgar DE, Meyer LJ et al (1992) Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science 258 1148-1152